Miki A - Search Results

1

Increased anticoagulant activity of warfarin used in combination with doxifluridine.

Nakajima M, Genda T, Suehira M, Satoh H, Miki A, Hori S, Sawada Y. Nakajima M, et al. Among authors: miki a. Cancer Chemother Pharmacol. 2010 Oct;66(5):969-72. doi: 10.1007/s00280-010-1249-5. Epub 2010 Jan 28. Cancer Chemother Pharmacol. 2010. PMID: 20107800

2

The first case of phenytoin intoxication associated with the concomitant use of phenytoin and TS-1, a combination preparation of tegafur, gimeracil, and oteracil potassium.

Tsuda A, Fujiyama J, Miki A, Hori S, Ohtani H, Sawada Y. Tsuda A, et al. Among authors: miki a. Cancer Chemother Pharmacol. 2008 Aug;62(3):427-32. doi: 10.1007/s00280-007-0621-6. Epub 2007 Nov 17. Cancer Chemother Pharmacol. 2008. PMID: 18026730

3

Sequential interaction of phenytoin and phenobarbital with fluorouracil.

Tsuda A, Miki A, Togawa T, Satoh H, Hori S, Sawada Y. Tsuda A, et al. Among authors: miki a. Int J Clin Pharmacol Ther. 2012 Dec;50(12):862-6. doi: 10.5414/CP201677. Int J Clin Pharmacol Ther. 2012. PMID: 23006440

4

Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model.

Miki A, Ohtani H, Sawada Y. Miki A, et al. J Clin Pharm Ther. 2011 Dec;36(6):642-50. doi: 10.1111/j.1365-2710.2010.01229.x. Epub 2010 Dec 8. J Clin Pharm Ther. 2011. PMID: 21143257 Review.

5

Individual differences in prothrombin time-international normalized ratio variation following coadministration of the anticancer agents S-1 and warfarin: 3 case reports.

Yamamuro F, Miki A, Kondo G, Maeda T, Satoh H, Hori S, Sawada Y. Yamamuro F, et al. Among authors: miki a. Int J Clin Pharmacol Ther. 2011 Nov;49(11):700-4. doi: 10.5414/cp201494. Int J Clin Pharmacol Ther. 2011. PMID: 22011696

6

Pharmacokinetic model analysis of interaction between phenytoin and capecitabine.

Miyazaki S, Satoh H, Ikenishi M, Sakurai M, Ueda M, Kawahara K, Ueda R, Ohtori T, Matsuyama K, Miki A, Hori S, Fukui E, Nakatsuka E, Sawada Y. Miyazaki S, et al. Among authors: miki a. Int J Clin Pharmacol Ther. 2016 Sep;54(9):657-65. doi: 10.5414/CP202416. Int J Clin Pharmacol Ther. 2016. PMID: 27390048

7

[Questionnaire survey on the change of asthmatic response, adverse events and product usability due to drug switching between name-brand and generic tulobuterol tapes].

Izumi T, Hori S, Satoh H, Miki A, Sawada Y. Izumi T, et al. Among authors: miki a. Yakugaku Zasshi. 2012;132(5):617-27. doi: 10.1248/yakushi.132.617. Yakugaku Zasshi. 2012. PMID: 22687698 Free article. Japanese.

8

Piloerection induced by replacing fluvoxamine with milnacipran.

Hori S, Matsuo N, Yamamoto A, Hazui T, Yagi H, Nakano M, Suzuki Y, Miki A, Ohtani H, Sawada Y. Hori S, et al. Among authors: miki a. Br J Clin Pharmacol. 2007 Jun;63(6):665-71. doi: 10.1111/j.1365-2125.2006.02838.x. Epub 2007 Feb 23. Br J Clin Pharmacol. 2007. PMID: 17324248 Free PMC article.

9

[Model analysis of tulobuterol patch formulations to explain the influence of drug release rate and transdermal transfer rate on the plasma concentration profile].

Watanabe T, Satoh H, Hori S, Miki A, Ohtani H, Sawada Y. Watanabe T, et al. Among authors: miki a. Yakugaku Zasshi. 2011;131(10):1483-92. doi: 10.1248/yakushi.131.1483. Yakugaku Zasshi. 2011. PMID: 21963976 Free article. Japanese.

10

Sisters who developed piloerection after administration of milnacipran.

Matsuo N, Hori S, Suehira M, Satoh H, Miki A, Sawada Y. Matsuo N, et al. Among authors: miki a. Int J Clin Pharmacol Ther. 2016 Mar;54(3):208-11. doi: 10.5414/CP202422. Int J Clin Pharmacol Ther. 2016. PMID: 26754308

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

681 results

Search Page

Filters